183 related articles for article (PubMed ID: 31578820)
1. SARI suppresses colitis-associated cancer development by maintaining MCP-1-mediated tumour-associated macrophage recruitment.
Dai L; Liu Y; Yin Y; Li J; Dong Z; Chen N; Cheng L; Wang H; Fang C; Lin Y; Shi G; Zhang H; Fan P; Su X; Zhang S; Yang Y; Yang L; Huang W; Zhou Z; Yu D; Deng H
J Cell Mol Med; 2020 Jan; 24(1):189-201. PubMed ID: 31578820
[TBL] [Abstract][Full Text] [Related]
2. SARI attenuates colon inflammation by promoting STAT1 degradation in intestinal epithelial cells.
Dai L; Liu Y; Cheng L; Wang H; Lin Y; Shi G; Dong Z; Li J; Fan P; Wang Q; Su X; Zhang S; Yang Y; Hu X; Huang W; Zhou Z; Yu D; Probert C; Wei Y; Deng H
Mucosal Immunol; 2019 Sep; 12(5):1130-1140. PubMed ID: 31182817
[TBL] [Abstract][Full Text] [Related]
3. Intestinal epithelium-derived BATF3 promotes colitis-associated colon cancer through facilitating CXCL5-mediated neutrophils recruitment.
Lin Y; Cheng L; Liu Y; Wang Y; Wang Q; Wang HL; Shi G; Li JS; Wang QN; Yang QM; Chen S; Su XL; Yang Y; Jiang M; Hu X; Fan P; Fang C; Zhou ZG; Dai L; Deng HX
Mucosal Immunol; 2021 Jan; 14(1):187-198. PubMed ID: 32467604
[TBL] [Abstract][Full Text] [Related]
4. SARI inhibits angiogenesis and tumour growth of human colon cancer through directly targeting ceruloplasmin.
Dai L; Cui X; Zhang X; Cheng L; Liu Y; Yang Y; Fan P; Wang Q; Lin Y; Zhang J; Li C; Mao Y; Wang Q; Su X; Zhang S; Peng Y; Yang H; Hu X; Yang J; Huang M; Xiang R; Yu D; Zhou Z; Wei Y; Deng H
Nat Commun; 2016 Jun; 7():11996. PubMed ID: 27353863
[TBL] [Abstract][Full Text] [Related]
5. Targeted demethylation of the SARI promotor impairs colon tumour growth.
Wang Q; Dai L; Wang Y; Deng J; Lin Y; Wang Q; Fang C; Ma Z; Wang H; Shi G; Cheng L; Liu Y; Chen S; Li J; Dong Z; Su X; Yang L; Zhang S; Jiang M; Huang M; Yang Y; Yu D; Zhou Z; Wei Y; Deng H
Cancer Lett; 2019 Apr; 448():132-143. PubMed ID: 30771439
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of TLR4 Signaling Impedes Tumor Growth in Colitis-Associated Colon Cancer.
Pastille E; Faßnacht T; Adamczyk A; Ngo Thi Phuong N; Buer J; Westendorf AM
Front Immunol; 2021; 12():669747. PubMed ID: 34025672
[TBL] [Abstract][Full Text] [Related]
7. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
[TBL] [Abstract][Full Text] [Related]
8. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
9. CD30L/CD30 signaling regulates the formation of the tumor immune microenvironment and inhibits intestinal tumor development of colitis-associated colon cancer in mice.
Wang X; Gao Y; Zhang X; Wang X; Wang B; Meng X; Yoshikai Y; Wang Y; Sun X
Int Immunopharmacol; 2020 Jul; 84():106531. PubMed ID: 32353687
[TBL] [Abstract][Full Text] [Related]
10. Suppression of Transmembrane Tumor Necrosis Factor Alpha Processing by a Specific Antibody Protects Against Colitis-Associated Cancer.
Ba H; Jiang R; Zhang M; Yin B; Wang J; Li Z; Li B; Zhou X
Front Immunol; 2021; 12():687874. PubMed ID: 34675913
[TBL] [Abstract][Full Text] [Related]
11. Expression and mechanism of action of the SARI tumor suppressor in prostate cancer.
Chen Q; Gu Y; Liu B
Int J Clin Exp Pathol; 2015; 8(7):7953-60. PubMed ID: 26339361
[TBL] [Abstract][Full Text] [Related]
12. Lack of STAT6 Attenuates Inflammation and Drives Protection against Early Steps of Colitis-Associated Colon Cancer.
Leon-Cabrera SA; Molina-Guzman E; Delgado-Ramirez YG; Vázquez-Sandoval A; Ledesma-Soto Y; Pérez-Plasencia CG; Chirino YI; Delgado-Buenrostro NL; Rodríguez-Sosa M; Vaca-Paniagua F; Ávila-Moreno F; Gutierrez-Cirlos EB; Arias-Romero LE; Terrazas LI
Cancer Immunol Res; 2017 May; 5(5):385-396. PubMed ID: 28385737
[TBL] [Abstract][Full Text] [Related]
13. Serum Amyloid A Promotes Inflammation-Associated Damage and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer.
Davis TA; Conradie D; Shridas P; de Beer FC; Engelbrecht AM; de Villiers WJS
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1329-1341. PubMed ID: 34217896
[TBL] [Abstract][Full Text] [Related]
14. STAT1 Is Required for Decreasing Accumulation of Granulocytic Cells via IL-17 during Initial Steps of Colitis-Associated Cancer.
Delgado-Ramirez Y; Baltazar-Perez I; Martinez Y; Callejas BE; Medina-Andrade I; Olguín JE; Delgado-Buenrostro NL; Chirino YI; Terrazas LI; Leon-Cabrera S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299314
[TBL] [Abstract][Full Text] [Related]
15. Macrophage targeting contributes to the inhibitory effects of embelin on colitis-associated cancer.
Wu T; Dai Y; Wang W; Teng G; Jiao H; Shuai X; Zhang R; Zhao P; Qiao L
Oncotarget; 2016 Apr; 7(15):19548-58. PubMed ID: 26799669
[TBL] [Abstract][Full Text] [Related]
16. Recruitment of M1 Macrophages May Not Be Critical for Protection against Colitis-Associated Tumorigenesis.
Medina-Andrade I; Olguín JE; Guerrero-García S; Espinosa JA; Garduño-Javier E; Hernández-Gómez V; Vaca-Paniagua F; Rodríguez-Sosa M; Terrazas LI
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681866
[TBL] [Abstract][Full Text] [Related]
17. TCF4 enhances hepatic metastasis of colorectal cancer by regulating tumor-associated macrophage via CCL2/CCR2 signaling.
Tu W; Gong J; Zhou Z; Tian D; Wang Z
Cell Death Dis; 2021 Sep; 12(10):882. PubMed ID: 34580284
[TBL] [Abstract][Full Text] [Related]
18. BMI1 and MEL18 Promote Colitis-Associated Cancer in Mice via REG3B and STAT3.
Liu X; Wei W; Li X; Shen P; Ju D; Wang Z; Zhang R; Yang F; Chen C; Cao K; Zhu G; Chen H; Chen L; Sui J; Zhang E; Wu K; Wang F; Zhao L; Xi R
Gastroenterology; 2017 Dec; 153(6):1607-1620. PubMed ID: 28780076
[TBL] [Abstract][Full Text] [Related]
19. Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1.
McClellan JL; Davis JM; Steiner JL; Enos RT; Jung SH; Carson JA; Pena MM; Carnevale KA; Berger FG; Murphy EA
Am J Physiol Gastrointest Liver Physiol; 2012 Nov; 303(10):G1087-95. PubMed ID: 23019193
[TBL] [Abstract][Full Text] [Related]
20. Epithelial derived-matrix metalloproteinase (MMP9) exhibits a novel defensive role of tumor suppressor in colitis associated cancer by activating MMP9-Notch1-ARF-p53 axis.
Walter L; Pujada A; Bhatnagar N; Bialkowska AB; Yang VW; Laroui H; Garg P
Oncotarget; 2017 Jan; 8(1):364-378. PubMed ID: 27861153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
